Fig. 4From: Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial(a) Aortic valve hemodynamic performance among patients implanted with aortic bioprosthesis at pre-procedure, and post-procedure till 12-month; (b) Mitral valve hemodynamic performance among patients implanted with mitral bioprosthesis at pre-procedure, and post-procedure till 12-monthBack to article page